Liquid lifeline: easier diabetes drug for infants passes key test
NCT ID NCT02375828
Summary
This study tested a new liquid version of a diabetes medicine for babies and children with a rare, genetic form of the disease. The goal was to see if this liquid is easier for young children to take and is as safe and effective as the current pill form. It involved 10 children who were already successfully using the pill version of the medicine to manage their condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL DIABETES SECONDARY TO MUTATION IN THE POTASSIUM CHANNEL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Universitaire Necker Enfants Malades
Paris, 7501, France
Conditions
Explore the condition pages connected to this study.